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Abstract
Hepatocellular carcinoma (HCC) is an aggressive tumor 
with poor long-term prognosis. Here, we present an 
unusual patient with a solitary recurrence of HCC in the 
right kidney 12 years after the initial diagnosis. This 
illustrates the importance of considering late recurrence 
in patients with a history of HCC and the management 
of these metastases.
© 2010 Baishideng. All rights reserved.
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INTRODUCTION
Hepatocellular carcinoma (HCC) is an aggressive tumor 
with poor long-term prognosis. The reported 5-year 
recurrence rate ranges from 75% to 100%[1]. Therefore, 
extrahepatic metastasis of  HCC is uncommon due to 
the highly malignant nature of  the primary tumor. How-
ever, with advances in different treatment modalities for 
HCC, the incidence of  extrahepatic metastasis appears 
to be increasing[2]. Nevertheless, most recurrences occur 
relatively early after the initial diagnosis and treatment. 
Here, we report a patient who presented with a renal tu-
mor 12 years after the initial treatment of  primary HCC, 
which turned out to be a solitary recurrence of  the initial 
HCC. The management of  these distant metastases is 
also highlighted.
Case RepORT
A 61-year-old man who was a chronic hepatitis B car-
rier with Child’s A liver cirrhosis, first presented 12 years 
ago with hemoperitoneum secondary to ruptured HCC. 
Emergency laparotomy for hemostasis was performed. 
Non-anatomical resection of  the liver tumor was sub-
sequently performed 1 mo later after his condition was 
optimized. Pathology showed an 8 cm × 6 cm × 4 cm, 
moderately differentiated HCC with a clear resection 
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margin. The postoperative serum α fetoprotein (AFP) 
level dropped from 1500 to 2 ng/mL. 
He was followed up regularly, 3-monthly for the first 
2 years, followed by half-yearly follow-up. Serum AFP 
was measured during each follow-up and abdominal 
ultrasound was also performed during each follow-up 
for the first 5 years and then yearly during subsequent 
follow-up. There was no evidence of  recurrence and 
the patient remained well clinically until 12 years later, 
when surveillance ultrasound revealed a right renal mass. 
Subsequent computed tomography showed a 5.3 cm 
pedunculated, well-circumscribed, contrast-enhanced 
soft tissue tumor in the right kidney, suspicious of  renal 
cell carcinoma (RCC) (Figure 1). There was no space-
occupying lesion in the liver or ascites. The tumor was 
asymptomatic and was not found on the last ultrasound 
performed 1 year ago. Serum AFP level was also in-
creased from 3 (6 mo previously) to 27 ng/mL. How-
ever, in view of  the long recurrence-free period and no 
evidence of  local recurrence, the treatment plan was 
to closely monitor the raised AFP level and proceed to 
treatment of  the renal mass.
With the past history of  laparotomy and hepatectomy, 
retroperitoscopic nephrectomy was planned. During the 
operation, a large vascular, friable and exophytic tumor 
was found to have developed in the right kidney. How-
ever, the tumor was quite adhesive to the surrounding 
tissue, such that it inadvertently ruptured despite careful 
dissection. The surgery was then converted to an open 
procedure. The operation lasted 195 min with an esti-
mated blood loss of  3 L. The post-operative course was 
uneventful and he was discharged 7 d after the operation.
However, the subsequent unexpected pathology was 
found to be extra-hepatic metastasis of  HCC at Gerota’s 
fascia. Macroscopically, the tumor was in the perineph-
ric fat with no invasion to the renal capsule (Figure 2). 
Microscopic examination showed trabeculae of  polygo-
nal eosinophilic tumor cells, with epithelial cohesion, 
marked pleomorphism, associated with sinusoidal-type 
vascular channels and bile canaliculi were also identified. 
The kidney and pelvi-calyceal system were intact. When 
compared with the previously resected HCC 12 years 
ago, they both demonstrated similar microscopic charac-
teristics and both were immunoreactive to polyclonal car-
cinoembryonic antigen and HepPar (Figure 3), but not to 
markers for RCC. Both the primary and recurrent HCC 
demonstrated the same TP53 mutation in exon 7 (R249S 
AGG > AGC). This result by itself  was not confirmatory, 
but supported the clonal relationship of  the primary and 
recurrent HCC in this case.
After nephrectomy, the patient’s serum AFP level 
dropped to 1 ng/mL, i.e. normal. As there was no evi-
dence of  other systemic recurrence, no adjuvant che-
motherapy was administered. The patient remained well 
18 mo after the nephrectomy and serum AFP remained 
normal. The latest positron-emission tomography per-
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Figure 1  Computed tomography showing the contrast-enhanced mass in 
the right kidney.
B
A
Figure 2  gross specimen of tumor showing its relationship with the right 
kidney. A: external appearance; B: from cut section of kidney.
Figure 3  Immunological stain of the tumor with HepPar, confirmed the 
tumor as hepatocellular carcinoma.
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formed at 1 year after nephrectomy showed no evidence 
of  recurrence.
DIsCUssION
In the past, extrahepatic metastasis of  HCC was consid-
ered a relatively uncommon phenomenon, owing to the 
highly malignant nature of  the primary tumor. None-
theless, with advances in treatment for HCC, its overall 
prognosis is improving and the incidence of  extrahepatic 
metastasis appears to be increasing[3]. The commonest 
sites of  extrahepatic metastases are lung, lymph node 
and bone followed by adrenal glands[4-6]. Extrahepatic 
metastasis can occur via three routes: hematogenous 
(56%), lymphogenous (27%) and direct invasion (22%) 
and more than one mode of  spread can occur[7]. It is un-
common for HCC to spread to kidney and most believe 
that tumor spread to the kidneys is via the hematogenous 
route[8]. In our patient, the metastasis spread to the peri-
nephric tissue without direct invasion of  kidney paren-
chyma. It was postulated that the initial rupture of  the 
primary liver tumor resulted in some seeding of  tumor 
cells in the retroperitoneal region giving rise to subse-
quent tumor recurrence. 
However, it is still extremely rare to have recurrent 
HCC 12 years after the initial diagnosis and treatment. 
The reported median duration between initial treatment 
for HCC to extrahepatic spread is 23.2 mo[1]. While there 
was a report suggesting that HCC can recur more than 
6 years after initial management[9], there are no reports 
of  recurrence occurring 10 years after initial treatment. 
It is difficult to explain the exceptionally long time lapse 
between treatment of  the primary tumor and the current 
recurrence in our patient. It can not be explained even 
by shed cells belonging to a very low malignant clone of  
tumor cells.
Although there is no standard management protocol 
for patients with extrahepatic metastasis of  HCC, it is 
generally believed that aggressive treatment for extrahe-
patic metastasis can prolong survival in selected patients 
with good performance status and limited volume of  re-
currence. In a review of  patients with both intrahepatic 
and extrahepatic recurrent HCC, patients who received 
an aggressive combination of  metastatectomy and lo-
coregional therapy, with or without systemic therapy, had 
a better survival rate compared to those who received 
only non-surgical treatment (median survival after recur-
rence was 44.0 mo in the aggressive treatment group 
vs 10.6 mo in the non-surgically treated group)[2]. For 
patients with lung metastasis, it was also shown that a 
longer disease-free interval from primary treatment and 
a smaller number of  metastasis (less than three) were as-
sociated with better prognosis[10]. In our patient, the soli-
tary nature and long disease-free interval were relatively 
good prognostic factors. 
Certainly, a more frequent follow-up protocol, espe-
cially imaging, may help to detect the lesion at an earlier 
stage. However, a careful balance between the yield and 
medical cost is needed, as late recurrence of  HCC after a 
disease-free period of  5 years is still a very rare condition.
Our case illustrates that, in managing patients with a 
past history of  HCC who present with new mass lesions, 
the diagnosis of  extra-hepatic metastasis should always 
be suspected. Although the final treatment might not be 
altered, the diagnosis of  metastatic HCC would allow 
better surgical planning and counseling for the patient.
ReFeReNCes
1 Ishii H, Furuse J, Kinoshita T, Konishi M, Nakagohri T, 
Takahashi S, Gotohda N, Nakachi K, Yoshino M. Extrahe-
patic spread from hepatocellular carcinoma: who are candi-
dates for aggressive anti-cancer treatment? Jpn J Clin Oncol 
2004; 34: 733-739
2 Poon RT, Fan ST, O'Suilleabhain CB, Wong J. Aggressive 
management of patients with extrahepatic and intrahepatic 
recurrences of hepatocellular carcinoma by combined re-
section and locoregional therapy. J Am Coll Surg 2002; 195: 
311-318
3 Kanda M, Tateishi R, Yoshida H, Sato T, Masuzaki R, Ohki T, 
Imamura J, Goto T, Yoshida H, Hamamura K, Obi S, Kanai F, 
Shiina S, Omata M. Extrahepatic metastasis of hepatocellu-
lar carcinoma: incidence and risk factors. Liver Int 2008; 28: 
1256-1263
4 Tanaka K, Shimada H, Matsuo K, Takeda K, Nagano Y, 
Togo S. Clinical features of hepatocellular carcinoma de-
veloping extrahepatic recurrences after curative resection. 
World J Surg 2008; 32: 1738-1747
5 Uka K, Aikata H, Takaki S, Shirakawa H, Jeong SC, Yamash-
ina K, Hiramatsu A, Kodama H, Takahashi S, Chayama K. 
Clinical features and prognosis of patients with extrahepatic 
metastases from hepatocellular carcinoma. World J Gastroen-
terol 2007; 13: 414-420
6 Natsuizaka M, Omura T, Akaike T, Kuwata Y, Yamazaki 
K, Sato T, Karino Y, Toyota J, Suga T, Asaka M. Clinical 
features of hepatocellular carcinoma with extrahepatic me-
tastases. J Gastroenterol Hepatol 2005; 20: 1781-1787
7 Texler ML, Pierides J, Maddern GJ. Case report: A hepa-
tocellular carcinoma metastasis in the distal pancreas. J 
Gastroenterol Hepatol 1998; 13: 467-470
8 Lo CM, Lai EC, Fan ST, Choi TK, Wong J. Resection for ex-
trahepatic recurrence of hepatocellular carcinoma. Br J Surg 
1994; 81: 1019-1021
9 Schreibman IR, Bejarano P, Martinez EJ, Regev A. Very 
late recurrence of hepatocellular carcinoma after liver trans-
plantation: case report and literature review. Transplant Proc 
2006; 38: 3140-3143
10 Kuo SW, Chang YL, Huang PM, Hsu HH, Chen JS, Lee JM, 
Lee PH, Lee YC. Prognostic factors for pulmonary metasta-
sectomy in hepatocellular carcinoma. Ann Surg Oncol 2007; 
14: 992-997
S- Editor  Wang JL    L- Editor  Webster JR    E- Editor  Zheng XM
2189 May 7, 2010|Volume 16|Issue 17|WJG|www.wjgnet.com
Wong TCL et al . Late recurrence of hepatocellular carcinoma
